Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Naing

Showing results (131-140 of 397) with videos related to

Pageof 40
Sort By:
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
Oncotarget|April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimusSarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
International Journal of Cancer|March 12, 2021
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I studyNizar M Tannir, Kyriakos P Papadopoulos, Deborah J Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experienceApostolia Maria Tsimberidou, Christos Vaklavas, Sijin Wen, et al.
Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.
Journal of Computer Assisted Tomography|December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver TumorsPayel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Cancer Chemotherapy and Pharmacology|March 6, 2010
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvementApostolia M Tsimberidou, Stacy Moulder, Siqing Fu, et al.
Oncotarget|November 27, 2014
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experienceMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Pageof 40

Showing results (131-140 of 397) with videos related to

Sort By:
Pageof 40
Cancer Chemotherapy and Pharmacology|December 25, 2015
Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastasesFu Siqing, Kirk S Culotta, Gerald S Falchook, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
Oncotarget|April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimusSarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.
International Journal of Cancer|March 12, 2021
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I studyNizar M Tannir, Kyriakos P Papadopoulos, Deborah J Wong, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experienceApostolia Maria Tsimberidou, Christos Vaklavas, Sijin Wen, et al.
Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.
Journal of Computer Assisted Tomography|December 1, 2017
Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver TumorsPayel Ghosh, Adam G Chandler, Brian P Hobbs, et al.
Cancer Chemotherapy and Pharmacology|March 6, 2010
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvementApostolia M Tsimberidou, Stacy Moulder, Siqing Fu, et al.
Oncotarget|November 27, 2014
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experienceMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Pageof 40